John Bognacki

Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.

Hal E. Broxmeyer, John Bognacki, M. Dörner et al. · The Journal of Experimental Medicine · 1981 · 187 citations · Full text

Immunotoxicology, Immunology, Blood Cell +20

Lactoferrin, transferrin and acidic isoferritins: regulatory molecules with potential therapeutic value in leukemia.

Broxmeyer He, Patrick S. Gentile, John Bognacki et al. · PubMed · 1983 · 56 citations

Immunology, Blood Cell, Immunotherapy +17

The human ENO1 gene product (recombinant human α-enolase) displays characteristics required for a plasminogen binding protein

Nicholas M. Andronicos, Marie Ranson, John Bognacki et al. · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · 1997 · 55 citations

Recombinant Human α-Enolase, Systems Biology, Molecular Physiology +8

Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins

AA Higazi, R. H. UPSON, RL Cohen et al. · Blood · 1996 · 50 citations · Full text

A subpopulation of human polymorphonuclear neutrophils contains an active form of lactoferrin capable of binding to human monocytes and inhibiting production of granulocyte-macrophage colony stimulatory activities.

Hal E. Broxmeyer, P Ralph, John Bognacki et al. · The Journal of Immunology · 1980 · 47 citations

Human Polymorphonuclear Neutrophils, Laboratory Immunology, Immunology +20